Aridis’ Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals
- Thursday, February 17, 2022, 7:12
- Business
- Add a comment
LOS GATOS, Calif., Feb. 17, 2022 /PRNewswire/ — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced today that both of its fully human…
About the Author
adminasapcorp has written 41806 stories on this site.